. De, plus sévères sont plus fréquemment traitées par corticothérapie (p = 0,02), la dose de corticoïdes est corrélée à l'activité de la maladie (R = +0,33, p = 0,012). 2.2

. La-cachexie-rhumatoïde, définie par Engvall comme FFMI < 10 th et FMI > 25 th

C. Dans-le-groupe, les patients tendent à être plus fréquemment traités par corticoïde (80 % vs 54 %, p = 0,13) et moins souvent par méthotrexate (50 % vs 74 %

D. Aletaha, T. Neogi, A. Silman, J. Funovits, D. Felson et al., 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis & Rheumatism, vol.61, issue.Suppl 31, pp.2569-2581, 2010.
DOI : 10.1002/art.27584

L. Rall and R. Roubenoff, Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions, Rheumatology, vol.43, issue.10, pp.1219-1223, 2004.
DOI : 10.1093/rheumatology/keh321

G. Summers, C. Deighton, M. Rennie, and A. Booth, Rheumatoid cachexia: a clinical perspective, Rheumatology, vol.47, issue.8, pp.1124-1131, 2008.
DOI : 10.1093/rheumatology/ken146

R. Roubenoff, Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century, Arthritis Research & Therapy, vol.11, issue.2, p.108, 2009.
DOI : 10.1186/ar2658

J. Singh, D. Furst, A. Bharat, J. Curtis, A. Kavanaugh et al., 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis, Arthritis Care & Research, vol.42, issue.Suppl, pp.625-639, 2008.
DOI : 10.1002/acr.21641

K. Upchurch and J. Kay, Evolution of treatment for rheumatoid arthritis, Rheumatology, vol.51, issue.suppl 6, pp.28-36, 2012.
DOI : 10.1093/rheumatology/kes278

T. Schaeverbeke, M. Truchetet, and C. Richez, When and where does rheumatoid arthritis begin?, Joint Bone Spine, vol.79, issue.6, pp.550-554, 2012.
DOI : 10.1016/j.jbspin.2012.09.004

D. Scott, F. Wolfe, and T. Huizinga, Rheumatoid arthritis, The Lancet, vol.376, issue.9746, pp.1094-1108, 2010.
DOI : 10.1016/S0140-6736(10)60826-4

C. Allaart and T. Huizinga, Treatment strategies in recent onset rheumatoid arthritis, Current Opinion in Rheumatology, vol.23, issue.3, pp.241-244, 2011.
DOI : 10.1097/BOR.0b013e3283454111

J. Anderson, L. Caplan, J. Yazdany, M. Robbins, T. Neogi et al., Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice, Arthritis Care & Research, vol.49, issue.Suppl, pp.640-647, 2012.
DOI : 10.1002/acr.21649

F. Guillemin, S. Brainçon, and J. Pourel, Measurement of the functional capacity in rheumatoid polyarthritis: a French adaptation of the Health Assessment Questionnaire (HAQ)]. Rev Rhum Mal Ostéo-Articul, juin, vol.58, issue.6, pp.459-465, 1991.

T. Boyd, A. Bonner, C. Thorne, G. Boire, C. Hitchon et al., The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Results from the CATCH Cohort, The Open Rheumatology Journal, vol.7, issue.1, pp.58-63, 2013.
DOI : 10.2174/1874312901307010058

B. Svensson, M. Andersson, S. Bala, K. Forslind, and I. Hafström, BARFOT study group. Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria, BMJ Open, vol.3, issue.9, p.3554, 2013.

C. Barnabe, J. Xiong, J. Pope, G. Boire, C. Hitchon et al., Factors associated with time to diagnosis in early rheumatoid arthritis, Rheumatol Int. 30 août, 2013.

B. Combe, R. Landewe, C. Lukas, H. Bolosiu, F. Breedveld et al., EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Annals of the Rheumatic Diseases, vol.66, issue.1, pp.34-45, 2007.
DOI : 10.1136/ard.2005.044354

A. Wells, R. Westhovens, D. Reed, L. Fanti, J. Becker et al., Abatacept Plus Methotrexate Provides Incremental Clinical Benefits Versus Methotrexate Alone in Methotrexate-naive Patients with Early Rheumatoid Arthritis Who Achieve Radiographic Nonprogression, The Journal of Rheumatology, vol.38, issue.11, pp.2362-2368, 2011.
DOI : 10.3899/jrheum.110054

M. Schneider and K. Krüger, Rheumatoid arthritis-early diagnosis and disease management, Dtsch Ärztebl Int. juill, vol.110, pp.27-28477, 2013.

B. Bannwarth, L. Labat, Y. Moride, and T. Schaeverbeke, Methotrexate in Rheumatoid Arthritis, Drugs, vol.47, issue.1, pp.25-50, 1994.
DOI : 10.2165/00003495-199447010-00003

A. Pierreisnard, N. Issa, T. Barnetche, C. Richez, and T. Schaeverbeke, Meta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naive or inadequately responsive to methotrexate, Joint Bone Spine, vol.80, issue.4, pp.386-392, 2013.
DOI : 10.1016/j.jbspin.2012.09.023

S. Marcora, K. Chester, G. Mittal, A. Lemmey, and P. Maddison, Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis, Am J Clin Nutr. déc, vol.84, issue.6, pp.1463-1472, 2006.

G. Metsios, A. Stavropoulos-kalinoglou, K. Douglas, Y. Koutedakis, A. Nevill et al., Blockade of tumour necrosis factor-?? in rheumatoid arthritis: effects on components of rheumatoid cachexia, Rheumatology, vol.46, issue.12, pp.1824-1827, 2007.
DOI : 10.1093/rheumatology/kem291

M. Hoene and C. Weigert, The role of interleukin-6 in insulin resistance, body fat distribution and energy balance, Obesity Reviews, vol.515, issue.1, pp.20-29, 2008.
DOI : 10.1172/JCI30453

S. Glund and A. Krook, Role of interleukin-6 signalling in glucose and lipid metabolism):37? 48. rheumatoid arthritis despite methotrexate: a network meta-analysis, Acta Physiol Oxf Engl. janv Arthritis Res Ther, vol.19213, issue.16, p.204, 2008.

J. Walsmith and R. Roubenoff, Cachexia in rheumatoid arthritis, International Journal of Cardiology, vol.85, issue.1, pp.89-99, 2002.
DOI : 10.1016/S0167-5273(02)00237-1

A. Coin, G. Sergi, N. Minicuci, S. Giannini, E. Barbiero et al., Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20???80 year-old Italian population, Clinical Nutrition, vol.27, issue.1, pp.87-94, 2008.
DOI : 10.1016/j.clnu.2007.10.008

E. Ferrannini, The theoretical bases of indirect calorimetry: A review, Metabolism, vol.37, issue.3, pp.287-301, 1988.
DOI : 10.1016/0026-0495(88)90110-2

G. Metsios, A. Stavropoulos-kalinoglou, V. Panoulas, Y. Koutedakis, A. Nevill et al., New resting energy expenditure prediction equations for patients with rheumatoid arthritis, Rheumatology, vol.47, issue.4, pp.500-506, 2008.
DOI : 10.1093/rheumatology/ken022

J. Cooney, R. Law, V. Matschke, A. Lemmey, J. Moore et al., Benefits of Exercise in Rheumatoid Arthritis, Journal of Aging Research, vol.31, issue.9, p.681640, 2011.
DOI : 10.3899/jrheum.090134

C. Chung, A. Oeser, J. Solus, T. Gebretsadik, A. Shintani et al., Inflammation???associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms, Arthritis & Rheumatism, vol.21, issue.7, pp.2105-2112, 2008.
DOI : 10.1002/art.23600

I. Engvall, A. Elkan, B. Tengstrand, T. Cederholm, K. Brismar et al., Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin???like growth factor, Scandinavian Journal of Rheumatology, vol.49, issue.5, pp.321-328, 2008.
DOI : 10.1002/art.1780390309

B. Targo?ska-st?pniak and M. Majdan, Associations between parameters of nutritional status and disease activity in patients with rheumatoid arthritis, Pol Arch Med Wewn?trznej. avr, vol.121, issue.4, pp.122-128, 2011.

Y. Henchoz, F. Bastardot, I. Guessous, J. Theler, J. Dudler et al., Physical activity and energy expenditure in rheumatoid arthritis patients and matched controls, Rheumatology, vol.51, issue.8, pp.1500-1507, 2012.
DOI : 10.1093/rheumatology/kes067

A. Elkan, I. Engvall, T. Cederholm, and I. Hafström, Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques, European Journal of Nutrition, vol.16, issue.5, pp.315-322, 2009.
DOI : 10.1007/s00394-009-0017-y

D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher et al., Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, vol.92, issue.7, pp.412-419, 1985.
DOI : 10.1007/BF00280883

R. Rabasa-lhoret and M. Laville, How to measure insulin sensitivity in clinical practice, Diabetes Metab. avr, vol.27, issue.2 2, pp.201-208, 2001.

J. Bastard, R. Rabasa-lhoret, M. Maachi, P. Ducluzeau, F. Andreelli et al., What kind of simple fasting index should be used to estimate insulin sensitivity in humans?, Diabetes & Metabolism, vol.29, issue.3, pp.285-288, 2003.
DOI : 10.1016/S1262-3636(07)70038-1

P. Dessein and B. Joffe, Insulin resistance and impaired beta cell function in rheumatoid arthritis, Arthritis & Rheumatism, vol.40, issue.9, pp.2765-2775, 2006.
DOI : 10.1002/art.22053

I. Stagakis, G. Bertsias, S. Karvounaris, M. Kavousanaki, D. Virla et al., Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance, Arthritis Research & Therapy, vol.14, issue.3, p.141, 2012.
DOI : 10.1136/ard.2009.113696

R. Kahn, J. Buse, E. Ferrannini, and M. Stern, The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, vol.28, issue.9, pp.2289-2304, 2005.
DOI : 10.2337/diacare.28.9.2289

D. Laaksonen, H. Lakka, L. Niskanen, G. Kaplan, J. Salonen et al., Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort Study, American Journal of Epidemiology, vol.156, issue.11, pp.1070-1077, 2002.
DOI : 10.1093/aje/kwf145

I. Ferraz-amaro, C. González-juanatey, R. López-mejias, L. Riancho-zarrabeitia, and M. González-gay, Metabolic Syndrome in Rheumatoid Arthritis, Mediators of Inflammation, vol.14, issue.4, p.710928, 2013.
DOI : 10.1038/nrrheum.2012.158

N. Sattar, A. Gaw, O. Scherbakova, I. Ford, O. Reilly et al., Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study, Circulation, vol.108, issue.4, pp.414-419, 2003.
DOI : 10.1161/01.CIR.0000080897.52664.94

C. Chung, A. Oeser, J. Solus, I. Avalos, T. Gebretsadik et al., Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis, Atherosclerosis, vol.196, issue.2, pp.756-763, 2008.
DOI : 10.1016/j.atherosclerosis.2007.01.004

D. Cunha, V. Brenol, C. Brenol, J. Fuchs, S. Arlindo et al., Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity, Scandinavian Journal of Rheumatology, vol.24, issue.3, pp.186-191, 2012.
DOI : 10.1093/rheumatology/36.4.444

S. Karvounaris, P. Sidiropoulos, J. Papadakis, E. Spanakis, G. Bertsias et al., Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study, Annals of the Rheumatic Diseases, vol.66, issue.1, pp.28-33, 2007.
DOI : 10.1136/ard.2006.053488

D. Cunha, V. Brenol, C. Brenol, J. Xavier, and R. , Rheumatoid arthritis and metabolic syndrome, Rev Bras Reumatol. juin, vol.51, issue.3, pp.260-268, 2011.

H. Maradit-kremers, C. Crowson, P. Nicola, K. Ballman, V. Roger et al., Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study, Arthritis & Rheumatism, vol.39, issue.2, pp.402-411, 2005.
DOI : 10.1002/art.20853

C. Chung, A. Oeser, P. Raggi, T. Gebretsadik, A. Shintani et al., Increased coronary-artery atherosclerosis in rheumatoid arthritis: Relationship to disease duration and cardiovascular risk factors, Arthritis & Rheumatism, vol.24, issue.10, pp.3045-3053, 2005.
DOI : 10.1002/art.21288

Y. Schutz, U. Kyle, and C. Pichard, Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98, Int J Obes Relat Metab Disord J Int Assoc Study Obes. juill, vol.26, issue.7, pp.953-960, 2002.

G. Almeida, M. Wasko, K. Jeong, C. Moore, and S. Piva, Physical Activity Measured by the SenseWear Armband in Women With Rheumatoid Arthritis, Physical Therapy, vol.91, issue.9, pp.1367-1376, 2011.
DOI : 10.2522/ptj.20100291

M. Tierney, A. Fraser, H. Purtill, and N. Kennedy, Study to Determine the Criterion Validity of the SenseWear Armband as a Measure of Physical Activity in People With Rheumatoid Arthritis, Arthritis Care & Research, vol.47, issue.6, pp.888-895, 2013.
DOI : 10.1002/acr.21914

C. Crowson, E. Myasoedova, J. Davis, E. Matteson, V. Roger et al., Increased Prevalence of Metabolic Syndrome Associated with Rheumatoid Arthritis in Patients without Clinical Cardiovascular Disease, The Journal of Rheumatology, vol.38, issue.1, pp.29-35, 2011.
DOI : 10.3899/jrheum.100346

T. Toms, V. Panoulas, K. Douglas, H. Griffiths, and G. Kitas, Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross sectional study, Arthritis Research & Therapy, vol.10, issue.6, p.145, 2008.
DOI : 10.1186/ar2578

K. Alberti, P. Zimmet, and J. Shaw, The metabolic syndrome???a new worldwide definition, The Lancet, vol.366, issue.9491, pp.1059-1062, 2005.
DOI : 10.1016/S0140-6736(05)67402-8

Y. Huang and X. Liu, Leisure-time physical activity and the risk of metabolic syndrome: meta-analysis, European Journal of Medical Research, vol.19, issue.1, p.22, 2014.
DOI : 10.1249/00149619-200310000-00001

J. Odegaard and A. Chawla, Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis, Science, vol.339, issue.6116, pp.172-177, 2013.
DOI : 10.1126/science.1230721

A. Goldfine, V. Fonseca, K. Jablonski, L. Pyle, M. Staten et al., The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes, Annals of Internal Medicine, vol.152, issue.6, pp.346-357, 2010.
DOI : 10.7326/0003-4819-152-6-201003160-00004

R. Roubenoff, R. Roubenoff, J. Cannon, J. Kehayias, H. Zhuang et al., Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation., Journal of Clinical Investigation, vol.93, issue.6, pp.2379-2386, 1994.
DOI : 10.1172/JCI117244

A. Arshad, R. Rashid, and K. Benjamin, The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism, Modern Rheumatology, vol.100, issue.6, pp.470-475, 2007.
DOI : 10.3109/s10165-007-0628-1

K. Binymin, A. Herrick, G. Carlson, and S. Hopkins, The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis, Journal of Inflammation Research, vol.4, pp.61-66, 2011.
DOI : 10.2147/JIR.S16508

A. Elkan, N. Håkansson, J. Frostegård, T. Cederholm, and I. Hafström, Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study, Arthritis Research & Therapy, vol.11, issue.2, p.37, 2009.
DOI : 10.1186/ar2643

S. Park, B. Goodpaster, J. Lee, L. Kuller, R. Boudreau et al., Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes, Diabetes Care, vol.32, issue.11, 1993.
DOI : 10.2337/dc09-0264

T. Shoji and Y. Nishizawa, Chronic Kidney Disease as a Metabolic Syndrome with Malnutrition???Need for Strict Control of Risk Factors, Internal Medicine, vol.44, issue.3, pp.179-187, 2005.
DOI : 10.2169/internalmedicine.44.179

H. Dao, Q. Do, and J. Sakamoto, Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study, Arthritis Research & Therapy, vol.12, issue.6, p.218, 2010.
DOI : 10.1186/ar3203

G. Summers, G. Metsios, A. Stavropoulos-kalinoglou, and G. Kitas, Rheumatoid cachexia and cardiovascular disease, Nature Reviews Rheumatology, vol.13, issue.8, pp.445-451, 2010.
DOI : 10.1038/nrrheum.2010.105

A. Elkan, I. Engvall, T. Cederholm, and I. Hafström, Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques, European Journal of Nutrition, vol.16, issue.5, pp.315-322, 2009.
DOI : 10.1007/s00394-009-0017-y

M. Burt, J. Gibney, and K. Ho, Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment, AJP: Endocrinology and Metabolism, vol.292, issue.5, pp.1426-1432, 2007.
DOI : 10.1152/ajpendo.00524.2006

C. Meune, E. Touzé, L. Trinquart, and Y. Allanore, High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis, Archives of Cardiovascular Diseases, vol.103, issue.4, pp.253-261, 2010.
DOI : 10.1016/j.acvd.2010.03.007

D. Solomon, T. Love, C. Canning, and S. Schneeweiss, Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis, Annals of the Rheumatic Diseases, vol.69, issue.12, pp.2114-2117, 2010.
DOI : 10.1136/ard.2009.125476

R. Roubenoff, J. Walsmith, N. Lundgren, L. Snydman, G. Dolnikowski et al., Low physical activity reduces total energy expenditure in women with rheumatoid arthritis: implications for dietary intake recommendations, Am J Clin Nutr. oct, vol.76, issue.4, pp.774-779, 2002.

A. Lemmey, S. Marcora, K. Chester, S. Wilson, F. Casanova et al., Effects of high-intensity resistance training in patients with rheumatoid arthritis: A randomized controlled trial, Arthritis & Rheumatism, vol.31, issue.12, pp.1726-1734, 2009.
DOI : 10.1002/art.24891

D. Jong, Z. Munneke, M. Zwinderman, A. Kroon, H. Ronday et al., Long term high intensity exercise and damage of small joints in rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.63, issue.11
DOI : 10.1136/ard.2003.015826

R. Pasquali and V. Vicennati, Steroids and the metabolic syndrome, The Journal of Steroid Biochemistry and Molecular Biology, vol.109, issue.3-5, pp.3-5258, 2008.
DOI : 10.1016/j.jsbmb.2008.03.009

P. Chanson and S. Salenave, Metabolic Syndrome in Cushing???s Syndrome, Neuroendocrinology, vol.92, issue.1, pp.96-101, 2010.
DOI : 10.1159/000314272

R. Roubenoff, R. Roubenoff, L. Ward, and M. Stevens, Catabolic effects of high-dose corticosteroids persist despite therapeutic benefit in rheumatoid arthritis, Am J Clin Nutr. déc, vol.52, issue.6, pp.1113-1117, 1990.

T. Toms, V. Panoulas, H. John, K. Douglas, and G. Kitas, Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study, Arthritis Research & Therapy, vol.11, issue.4, p.110, 2009.
DOI : 10.1186/ar2765

H. Hayashi, K. Satoi, N. Sato-mito, T. Kaburagi, H. Yoshino et al., Nutritional status in relation to adipokines and oxidative stress is associated with disease activity in patients with rheumatoid arthritis, Nutrition, vol.28, issue.11-12, pp.11-121109, 2012.
DOI : 10.1016/j.nut.2012.02.009

. Dans-la-polyarthrite-rhumatoïde, Communication affichée, Journées francophones de nutrition, 2011.

C. Fagour, B. Cherifi, C. Gonzalez, A. Maury, H. Gin et al., Mesurer la d??pense ??nerg??tique en pratique clinique, M??decine des Maladies M??taboliques, vol.7, issue.6, pp.525-532, 2013.
DOI : 10.1016/S1957-2557(13)70703-X